Crossmark

Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2

Crossref DOI link: https://doi.org/10.1038/s41418-018-0142-3

Published Online: 2018-06-13

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bittremieux, Mart

La Rovere, Rita M.

Akl, Haidar

Martines, Claudio

Welkenhuyzen, Kirsten

Dubron, Kathia

Baes, Myriam

Janssens, Ann

Vandenberghe, Peter

Laurenti, Luca

Rietdorf, Katja

Morciano, Giampaolo

Pinton, Paolo https://orcid.org/0000-0001-7108-6508
Mikoshiba, Katsuhiko

Bootman, Martin D. https://orcid.org/0000-0002-6447-3451
Efremov, Dimitar G.

De Smedt, Humbert

Parys, Jan B. https://orcid.org/0000-0002-3591-4967
Bultynck, Geert https://orcid.org/0000-0002-5968-4828
Funding

Funding for this research was provided by:

Fonds Wetenschappelijk Onderzoek (G.0571.12N)

Fonds Wetenschappelijk Onderzoek (G.0634.13N)

Fonds Wetenschappelijk Onderzoek (G.0C91.14N)

Fonds Wetenschappelijk Onderzoek (G.0A34.16N)

Fonds Wetenschappelijk Onderzoek (G.0A34.16N)

Bijzonder Onderzoeksfonds (OT14/101)
License Information

Text and Data Mining valid from 2018-06-13
More Information

Article History

Received: 30 July 2017

Revised: 15 May 2018

Accepted: 16 May 2018

First Online: 13 June 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.